Left ventricular shape variation in asymptomatic populations: the multi-ethnic study of atherosclerosis by unknown
Medrano-Gracia et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:56
http://jcmr-online.com/content/16/1/56RESEARCH Open AccessLeft ventricular shape variation in asymptomatic
populations: the multi-ethnic study of
atherosclerosis
Pau Medrano-Gracia1, Brett R Cowan1, Bharath Ambale-Venkatesh2, David A Bluemke3, John Eng2, John Paul Finn4,
Carissa G Fonseca4, Joao AC Lima2, Avan Suinesiaputra1 and Alistair A Young1*Abstract
Background: Although left ventricular cardiac geometric indices such as size and sphericity characterize adverse
remodeling and have prognostic value in symptomatic patients, little is known of shape distributions in subclinical
populations. We sought to quantify shape variation across a large number of asymptomatic volunteers, and
examine differences among sub-cohorts.
Methods: An atlas was constructed comprising 1,991 cardiovascular magnetic resonance (CMR) cases contributed
from the Multi-Ethnic Study of Atherosclerosis baseline examination. A mathematical model describing regional wall
motion and shape was used to establish a coordinate map registered to the cardiac anatomy. The model was
automatically customized to left ventricular contours and anatomical landmarks, corrected for breath-hold
mis-registration between image slices. Mathematical techniques were used to characterize global shape
distributions, after removal of translations, rotations, and scale due to height. Differences were quantified among
ethnicity, sex, smoking, hypertension and diabetes sub-cohorts.
Results: The atlas construction process yielded accurate representations of global shape (errors between manual
and automatic surface points in 244 validation cases were less than the image pixel size). After correction for
height, the dominant shape component was associated with heart size, explaining 32% of the total shape variance
at end-diastole and 29% at end-systole. After size, the second dominant shape component was sphericity at
end-diastole (13%), and concentricity at end-systole (10%). The resulting shape components distinguished
differences due to ethnicity and risk factors with greater statistical power than traditional mass and volume indices.
Conclusions: We have quantified the dominant components of global shape variation in the adult asymptomatic
population. The data and results are available at cardiacatlas.org. Shape distributions were principally explained by
size, sphericity and concentricity, which are known correlates of adverse outcomes. Atlas-based global shape
analysis provides a powerful method for quantifying left ventricular shape differences in asymptomatic populations.
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Adverse remodeling of the left ventricle (LV) can be de-
fined as a change in shape due to cardiovascular disease
which is associated with worse prognostic outcome [1].
For example, increased end-systolic volume is a pre-
dictor of mortality in patients after myocardial infarc-
tion [2]. LV sphericity, or length to width ratio, has also
been associated with decreased survival [3] and is pre-
dictive of subsequent volume increase [4] in these pa-
tients. Concentric hypertrophy, or wall to cavity ratio, is
predictive of adverse events in hypertension [5]. How-
ever, characterization of global shape change in health
and disease has been difficult due to the lack of a stan-
dardized map of the heart. In order to quantify the
large-scale shape changes undergone in patients with
clinical disease, the variation present in the asymptom-
atic population must first be characterized.
In the Framingham study of asymptomatic individuals,
LV chamber dimension was associated with increased ad-
verse events [6], as were lower systolic dimension change
[7], and hypertrophy [8]. However, simple volume or di-
mension measures fail to capture the wealth of data avail-
able in modern non-invasive imaging examinations. Access
to this information would be very useful for the quantifica-
tion of subclinical disease in the asymptomatic population
and the evaluation of disease severity in patient groups.
The Multi-Ethnic Study of Atherosclerosis (MESA)
was initiated in July 2000 to investigate the prevalence,
correlates, and progression of subclinical cardiovascular
disease in a population-based sample of 6,814 men and
women aged 45–84 years [9]. Cardiovascular magnetic
resonance (CMR) was used in MESA to evaluate cardiac
mass and volume [10]. A subset of CMR cases from the
MESA baseline examination, together with contours
from the CMR core laboratory and clinical information
from the coordinating center, were contributed to the
Cardiac Atlas Project (CAP) to provide a resource for
cardiac image data sharing and atlas-based shape ana-
lysis for population studies [11].
Principal component analysis (PCA) is an established
mathematical technique for quantifying the statistical
variation of global shape in population atlases, and
promises to provide novel information on the pathogen-
esis of neurological and cardiovascular disease [11-15].
However, the application of PCA in sub-clinical volun-
teers has not been investigated.
In this study, we sought to establish the most important
components of LV shape and function (known as principal
components) present in the MESA cohort contributed to
CAP. Automated methods were developed to build an
atlas from contour and landmark information. We hy-
pothesized that the principal components of global LV
shape in the asymptomatic population are associated with
traditional indices of adverse remodeling, and that PCAcan more clearly distinguish differences between sub-
cohorts than current indices of remodeling such as mass
and volume.Methods
Participants
A total of 1,991 MESA CMR cases with matching con-
tours and landmark information were obtained from the
CAP database (www.cardiacatlas.org). These represented a
random sample of the MESA baseline CMR examinations
contributed to CAP with local Institutional Review Board
approval. Informed participant consent compatible with
sharing of de-identified data was obtained in all cases.
Imaging studies and derived analyses were de-identified
in a HIPAA compliant manner, annotated using standard
ontological schema, stored in a web-accessible picture ar-
chiving and communication system (PACS) database, and
analyzed using atlas-based techniques [11]. Participants
were asymptomatic and free of clinical indications of car-
diovascular disease at baseline, and standard risk factor
profiles including smoking, hypertension, and fasting glu-
cose data were obtained [9]. Ethnicity was determined by
participant self-identification.
CMR was performed as part of the baseline MESA
examination during 2000–2002. Images were acquired on
1.5 T scanners using a four element phased-array coil, as
described previously [10]. Fast gradient recalled echo cine
images were acquired with 10–12 short axis slices and one
four chamber long axis slice (6 mm thickness, 4 mm gap,
field of view 360–400 mm, 256 × 160 matrix, flip angle
20°, echo time 3–5 ms, repetition time 8–10 ms) with
20–30 frames per slice (temporal resolution <50 ms). The
pixel size varied from 1.4 to 2.5 mm/pixel depending on
patient size. Each slice was acquired in a separate breath-
hold. Contours were manually drawn as a series of points
by the MESA CMR core lab on short-axis slices for all
cases at end-diastole (ED) and end-systole (ES) [10] using
Q-MASS software (v. 4.2, Medis, the Netherlands).
For a typical case with 7–10 short-axis slices, a total
of ~2,000 contour points were available.
CMR LV mass and volume data for this cohort are
shown in Table 1.Atlas construction
The overall construction process for the atlas is shown
in Figure 1. Fiducial landmarks were manually placed at
the centroid of the LV cavity on the apical and basal ED
short axis images, the hinge points of the mitral valve
in the ED long axis image (Figure 1a), and at the inser-
tions of the right ventricular free wall into the inter-
ventricular septum in the ED short axis images. These
were used to define a patient specific coordinate system
which although individualized, was generally aligned in
Table 1 CMR LV mass and volume calculated from the CMR core lab contours using slice summation
EDVI (ml/m2.7) ESVI (ml/m2.7) LVMI (g/m2.7) EF (%)
Total 1,991 31.7 ± 6.6 9.9 ± 3.9 36.7 ± 8.4 69 ± 8
Sex Female 1,034 31.6 ± 6.1 8.9 ± 2.9 35.1 ± 7.6 72 ± 6
Male 957 31.7 ± 7.1 10.8 ± 4.5 38.4 ± 8.8 66 ± 8
Ethnicity White1 739 30.6 ± 6.24 9.7 ± 3.42,4 35.2 ± 7.22,3,4 67 ± 72
Chinese2 356 30.1 ± 5.03,4 8.4 ± 2.51,3,4 33.1 ± 6.31,3,4 72 ± 61,3,4
Black3 405 31.8 ± 7.32,4 10.4 ± 4.52 38.4 ± 9.51,2 68 ± 82
Hispanic4 491 34.4 ± 6.71,2,3 10.8 ± 4.31,2 39.9 ± 8.91,2 69 ± 82
Smoking Never1 1,053 31.8 ± 6.1 9.5 ± 3.33 35.9 ± 7.73 70 ± 72,3
Former2 682 31.5 ± 7.1 10.1 ± 4.3 37.1 ± 9.0 68 ± 81
Current3 249 32.0 ± 7.2 10.7 ± 4.31 38.3 ± 9.01 67 ± 71
Alcohol Never1 490 31.3 ± 5.8 9.0 ± 3.12,3 35.4 ± 7.72 72 ± 72,3
Former2 492 31.8 ± 7.2 10.0 ± 4.31 37.5 ± 8.91 69 ± 81
Current3 990 31.9 ± 6.7 10.2 ± 3.91 36.8 ± 8.4 68 ± 71
Hypertension No 1,135 31.2 ± 6.3 9.9 ± 3.6 34.8 ± 7.2 69 ± 7
Yes 856 32.3 ± 7.0 9.8 ± 4.2 39.1 ± 9.2 70 ± 8
Diabetes Normal1 1,444 31.6 ± 6.5 9.8 ± 3.6 35.8 ± 7.92,3,4 69 ± 7
Impaired fasting glucose2 285 31.6 ± 6.3 9.7 ± 3.7 37.8 ± 8.31 70 ± 8
Untreated diabetes3 58 33.0 ± 6.8 11.0 ± 4.0 40.9 ± 10.91 67 ± 9
Treated diabetes4 203 32.5 ± 7.7 10.3 ± 5.4 40.2 ± 9.41 69 ± 9
Significant differences by ANOVA (p < 0.005) are highlighted in bold-face. Scheffé’s multiple-comparison post-hoc tests are represented by super-indices indicating
differences between the labeled sub-cohorts at an α-level of 0.005 (when significant differences were found in categorical variables).
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of the model, as described in the Appendix.
The model coordinates were used to provide the atlas
coordinates of the LV: each point was assumed to be in
the same anatomical location and this allowed alignment
of the hearts of all patients [16].a
cb
Figure 1 Flow chart of the atlas construction. (a) Fiducial landmarks de
Red markers denote the mitral valve and purple markers denote the interse
plane is drawn as a yellow disc. (b) Contours drawn on short axis slices by
mis-alignment between slices. (c) 3D finite element model showing epicar
(d) Breath-hold mis-registration correction by alignment to the model. (e)
panels show ±2 standard deviations in the principal component shape.Automated model customization
Models were customized to each case by fitting the math-
ematical endocardial and epicardial surface model to the
landmarks and short axis contours [17]. A 3D plane was
fitted to the mitral valve hinge points to accurately repre-






fined at ED on short and long axis images (3D view from anterior).
ctions of the right ventricular free wall and the septum. The base
the core lab. Individual breath-holds for each 2D slice result in
dial control points (model shape parameters) and element boundaries.
Principal component analysis of atlas shape variation. Upper and lower

























1.836 - 0.005 * height
Figure 2 Scale factor calculated from Procrustes alignment,
plotted against body height. The linear regression line (black) was
used to provide a scale factor for each case to correct heart size for
body habitus.
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in the breath-hold position from slice to slice (Figure 1b)
were automatically corrected by shifting the contours in-
plane to match an initial model fit (see Appendix).
Validation
In order to validate the automated customization and
breath-hold correction method, a random sample of 244
cases were independently analyzed by expert users who
manually customized the models to each case using guide-
point modeling blinded to the automated results [18]. The
model was interactively customized to each case by placing
guide points on the epicardial and endocardial images using
custom software (CIM v. 6.0, Auckland, New Zealand). In-
plane shifting of the slices was manually performed by the
user to correct for breath-hold mis-registrations. This
method has been previously validated against autopsy LV
mass in animals, in patients against manually drawn con-
tours, and in healthy volunteers against flow-derived mea-
surements of cardiac output [18].
To calculate the error between the automated and
manual methods, the sampled points from both ma-
nually customized and automatically generated shape
models were pair-wise aligned by rigid body rotation to
ensure maximum alignment using the Kabsch algorithm
[19]. The error was then calculated as the root mean
squared distance between corresponding points on both
models.
Atlas based analysis
In atlas-based analyses, differences due to pose (transla-
tion and rotation) and scale (uniform size) are typically
removed from all cases before performing the shape ana-
lysis. We used a scaled Procrustes alignment [20] to de-
termine the pose and a scale factor for each shape
model relative to the mean, and removed these effects.
However, changes in heart size beyond that predicted by
body habitus are known to occur due to disease pro-
cesses. Removal of all size information would therefore
be counterproductive in the current application. Figure 2
shows that the relationship between scale factor and
height was approximately linear across the entire cohort.
We therefore scaled each heart according to its height
predicted scale factor obtained from the linear regres-
sion line, thereby retaining any residual size (i.e. not pre-
dicted by height) in the subsequent shape analysis.
Principal component analysis (PCA) was used to find
the most important global shape variations in the atlas
[11,14]. Firstly, the three-dimensional positions of a large
number of points uniformly placed on the smoothed
epicardial and endocardial surfaces of the LV were calcu-
lated (Appendix). PCA finds the smallest number of sta-
tistically independent shapes, (or components), which
explain as much of the global shape variation as possible[21] (see Appendix for details). Traditional measures of
shape, such as volume, thickness, and dimensional shape
changes, are thus inherently included within the princi-
pal shape components. The first component has the lar-
gest possible variance, which accounts for as much of
the variability in the data as possible, and each succeed-
ing component in turn explains as much of the residual
variability as possible. Two separate PCAs were per-
formed, using ED shapes and ES shapes separately.
In order to test the hypothesis that principal com-
ponents are better than standard remodeling indices of
mass and volume in determining shape differences be-
tween sub-cohorts, we applied linear discriminant ana-
lysis (LDA) to characterize shape differences [22]. This
method provided the optimum way of distinguishing be-
tween sub-cohorts for both PCA and standard measures.
Statistics
The strength of each component present in a particular
case was calculated by projection (see Appendix) and
normalized as a z score (mean of 0, standard deviation
of 1.0 across the whole cohort). Comparisons of z scores
for the first two components were tested using ANOVA
for each dependent variable (sex, ethnicity, smoking, al-
cohol, hypertension and diabetes). Note that z-scoring
has no effect in the ANOVAs. Post-hoc tests were per-
formed using the Scheffé test. A more stringent p value
of 0.005 was considered significant [23]. Linear discrim-
inant analysis was applied to the first two components,
the first 50 components, and standard remodeling mea-
sures of mass and volume. Effect size between sub-
cohorts was quantified with Cohen’s d, which measures
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The error, quantified in 244 cases between the automatic
and expert-derived models, was (mean ± std.dev.) 1.1 ±
0.6 mm at ED and 0.9 ± 0.5 mm at ES. The model fit
error between the contour points and the model surfaces
from the 1,991 cases was 0.5 ± 0.4 mm at ED and 0.5 ±
0.6 mm at ES. These were less than the pixel size of 1.4-
2.5 mm.
Atlas components
Figure 3 shows the first and second principal compo-
nents for each of the ED and ES atlases. At ED, the first
principal component (component 1) accounted for 32%
of the total variation (Figure 3 left, top) and visually, this
component was primarily associated with heart size. We
therefore call this component “size” for convenience al-
though it is not a pure scaling. The second principal
component at ED accounted for 13% of the total vari-
ation (Figure 3 right, top). Since this was associated with
the height to width ratio we call this component “spher-
icity”, although it is not a pure height to width scaling.
At ES, 30% of the total variation was explained by the
first principal component (Figure 3 left, bottom), which
was associated with size (similar to ED component 1). The
second component (10% of total variation) was associated
with the ratio of cavity volume to wall volume (Figure 3
right, bottom). We call this component “concentricity”






Figure 3 First and second principal shape components of variation in
and right shapes represent the mean ± 2 std. dev. in the component distribconcentric shape at ES. The third component (9%, not
shown) was associated with ventricular sphericity at ES.
The strength of each component present was quanti-
fied (Appendix) and the z-scored weights of these coeffi-
cients in the first two principal components are shown
in Table 2.
Table 2 shows that significant differences were found
due to sex at ED, with males having larger size (z score
0.17 vs −0.16, or a difference of 33% of the cohort stand-
ard deviation), and less spherical hearts (22%). At ES
male hearts were larger (43%) and less concentric
(108%). For ethnicity, significant differences in residual
size were found at ED, with Hispanics having the largest
hearts, and Chinese the smallest, with a difference of
76% between these groups (after correction for height).
This pattern was preserved at ES, but Hispanics were
also the most concentric (72% difference from Whites).
Among risk factor sub-cohorts in Table 2, smoking was
associated with greater size and less concentricity at ES,
with increasing effect from Never to Former to Current
(32% for size and 44% for concentricity between Never
and Current). Similarly alcohol consumption was associ-
ated with greater size at ED (20%) and ES (29%) and less
concentricity at ES (69%), between Never and Current.
Hypertension was associated with larger size (21%) and
sphericity (24%) at ED and larger size (18%) and more con-
centricity (37%) at ES. Diabetes was associated with higher
concentricity at ES, with increasing effect from Normal to
Impaired Fasting Glucose to Untreated Diabetes to
Treated Diabetes (31% between Normal to Treated).
Table 3 shows the results of the LDA for the first two




the atlas (N = 1,991) for ED and ES. For each component the left
ution. Viewpoint is from the septum, posterior wall on the right.
Table 2 Projection onto first two principal shape components for sub-cohorts
N ED ES
Component 1 Component 2 Component 1 Component 2
“Residual size” “Sphericity” “Residual size” “Concentricity”
Sex Female 1,034 −0.16 ± 0.92 0.11 ± 0.98 −0.21 ± 0.88 0.52 ± 0.82
Male 957 0.17 ± 1.05 −0.11 ± 1.01 0.22 ± 1.07 −0.56 ± 0.86
Ethnicity White1 739 −0.18 ± 0.943,4 −0.04 ± 0.97 −0.12 ± 0.902,3,4 −0.30 ± 0.962,4
Chinese2 356 −0.34 ± 0.803,4 −0.05 ± 0.90 −0.49 ± 0.771,3,4 0.30 ± 0.841,3
Black3 405 0.11 ± 1.081,2,4 −0.02 ± 1.08 0.24 ± 1.121,2 −0.22 ± 1.012,4
Hispanic4 491 0.42 ± 1.001,2,3 0.11 ± 1.03 0.34 ± 1.011,2 0.42 ± 0.961,3
Smoking Never1 1,053 −0.04 ± 0.94 0.04 ± 0.97 −0.08 ± 0.933 0.18 ± 0.992,3
Former2 682 0.03 ± 1.06 −0.05 ± 1.02 0.03 ± 1.07 −0.19 ± 0.981
Current3 249 0.10 ± 1.08 −0.04 ± 1.04 0.24 ± 1.061 −0.24 ± 0.971
Alcohol Never1 490 −0.14 ± 0.893 0.05 ± 0.94 −0.21 ± 0.902,3 0.46 ± 0.892,3
Former2 492 0.02 ± 1.07 0.02 ± 1.10 0.05 ± 1.061 0.01 ± 0.971,3
Current3 990 0.06 ± 1.011 −0.03 ± 0.98 0.08 ± 1.011 −0.23 ± 0.981,2
Hypertension No 1,135 −0.09 ± 0.97 −0.10 ± 0.94 −0.08 ± 0.93 −0.16 ± 0.97
Yes 856 0.12 ± 1.03 0.14 ± 1.06 0.10 ± 1.07 0.21 ± 1.01
Diabetes Normal1 1,444 −0.04 ± 1.00 −0.03 ± 1.00 −0.04 ± 0.98 −0.07 ± 0.994
Impaired fasting glucose2 285 0.06 ± 0.94 0.01 ± 0.93 0.05 ± 0.99 0.15 ± 0.95
Untreated diabetes3 58 0.23 ± 1.05 0.23 ± 1.08 0.25 ± 1.08 0.22 ± 1.12
Treated diabetes4 203 0.16 ± 1.08 0.11 ± 1.05 0.16 ± 1.13 0.24 ± 1.051
Z-scores of the projected weights are shown for each sub-cohort and component (mean ± std. dev.). Significant differences (p < 0.005) are highlighted in bold-face.
Scheffé’s multiple-comparison post-hoc tests are represented by super-indices indicating differences between the labeled sub-cohorts at an α-level of 0.005
(when significant differences were found in categorical variables). Sub-cohorts may not add to 1991 due to missing data.
Table 3 Linear discriminant analysis for first two principal shape components (LDA2) and first 50 components (LDA50)
compared with standard remodeling indices (Standard)
LDA2 LDA50 Standard
ED ES ED ES EF EDVI ESVI LVMI
Smoking -log(p) 2 21 46 46 11 0 5 4
Cohen’s d 0.13 0.43 0.67 0.66 0.30 0.02 0.20 0.18
Diabetes -log(p) 4 9 49 48 0 1 1 14
Cohen’s d 0.18 0.30 0.77 0.75 0.02 0.08 0.07 0.40
Hypertension -log(p) 12 20 113 101 5 3 0 30
Cohen’s d 0.33 0.42 1.09 1.03 0.20 0.16 0.03 0.53
Sex -log(p) 19 182 >200 >200 62 0 28 18
Cohen’s d 0.41 1.44 2.34 2.23 0.78 0.02 0.51 0.40
White -log(p) 9 29 93 96 2 8 1 8
Cohen’s d 0.29 0.53 1.01 1.02 0.12 0.27 0.08 0.27
Chinese -log(p) 12 33 79 98 16 7 15 19
Cohen’s d 0.43 0.72 1.16 1.30 0.49 0.30 0.48 0.53
Black -log(p) 2 13 81 67 5 0 3 6
Cohen’s d 0.15 0.41 1.12 1.01 0.25 0.02 0.18 0.27
Hispanic -log(p) 28 44 93 79 0 26 9 23
Cohen’s d 0.59 0.75 1.13 1.03 0.02 0.57 0.32 0.53
For ethnicity each test compares one group with the rest (e.g. white vs. non-white). Significance is quantified by –log(p) (e.g. for p = 0.001, −log(p) = 3). Effect size
is measured by Cohen’s d, which can be interpreted as the mean distance between two groups in standard deviations (e.g. males and females were separated by
2.34 standard deviations in the LDA50 ED analysis). Bold-faced numbers highlight the highest separation achieved by PCA vs. standard remodeling indices.
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cant differences (lower p value) and greater effect sizes
(measured with Cohen’s d [24]) than standard measures
in most cases. The 50 component LDA showed greater
discriminatory power than both.
Discussion
Although atlas-based shape analysis is well established
in neurological imaging [12,13], application to cardiac
disease has been limited [11,14,15]. Atlas-based analysis
has the potential to reveal new measures of geometry
and function, which may provide novel insights into the
remodeling processes of disease. For example, Lewan-
dowski et al. [15] recently showed significant differences
in principal components between individuals born pre-
term (30 weeks) and full-term age matched healthy vol-
unteers, which are indicative of cardiac remodeling
associated with the premature switch to post-natal
circulation.
There has been limited information on the distribution
of global shape inherent in the asymptomatic popula-
tion. We have created one of the largest atlases of the
left ventricle to date, built from 1,991 models. The data
and results are available on request from www.cardiaca-
tlas.org. The main application of this atlas is to quantify
adverse remodelling in clinical patients, standardized
against the asymptomatic population atlas, by calculating
the strength of each principal component present in a
particular patient. Changes over time, or the effect of
treatment, can then be precisely quantified by progres-
sion of the component coefficients.
Our results showed that the first principal component
of shape variation at ED and ES was associated with
heart size, accounting for about 30% of the total vari-
ance. Significant differences were found in this compo-
nent due to sex, ethnicity, smoking (ES only), alcohol,
and hypertension. This confirms the importance of heart
size as the dominant morphological index, even after
correction for body size. The differences in the size com-
ponent between sub-cohorts (Table 2) mirrored the dif-
ferences in mass and volume (Table 1). In asymptomatic
individuals, heart size has been associated with adverse
events in the Framingham study using chamber dimen-
sion [6], and with heart failure in the MESA cohort
using EDV and LV mass [25]. Volume and mass also dif-
fered with standard risk factors of smoking, hypertension
and diabetes in the MESA cohort [26]. In patients with
myocardial infarction, ESV is a strong predictor of mor-
tality [2]. ESV also predicted adverse events in high risk
patients in the ONTARGET study [27].
The second component of shape variation was associ-
ated with sphericity at ED, and this was also associated
with the third component at ES. In a CMR study of 120
asymptomatic volunteers, women had more sphericalventricles than men [28], in agreement with our results.
In patients with myocardial infarction, sphericity has
been associated with decreased survival [3] and is a pre-
dictor of future gain in LV volume [4]. Sphericity was
also shown to be the primary geometric determinant of
functional mitral regurgitation in heart failure [29]. Cav-
ity shape was more spherical in hypertensive patients
with eccentric hypertrophy [30]. In advanced idiopathic
dilated cardiomyopathy, increased sphericity has been
linked to poorer survival [6], increased metalloproteinase
activity and loss of collagen [31]. Our results support the
hypothesis that sphericity is an important shape des-
criptor in asymptomatic individuals as well as patients.
Atlas-based sphericity measures can be simply calculated
in individuals by projection onto the sphericity compo-
nent. Since the components are orthogonal, this measure
of sphericity is independent from the other components
of shape variation.
The second component at ES was associated with the
ratio of wall thickness to cavity size, which is indicative
of concentric remodeling [30]. Further work is needed
to determine if this component was due primarily to
wall thickening, i.e. a difference between ED and ES, or
with wall thickness at ED. However, this component
of remodeling is well known to be clinically associated
with adverse outcomes [5]. In the Framingham study of
asymptomatic volunteers, concentric remodeling was as-
sociated with increased risk of incident cardiovascular
disease [32].
It is important to note that the shapes produced by
PCA are determined solely by the data, and each con-
tains global shape information pertaining to all regions.
The use of the terms ‘size’ and ‘sphericity’ are ways of la-
belling the components in a clinically meaningful way,
but the shape information is more complex than this as
it varies regionally in a complex way as determined by
the data.
Limitations
Limitations of this study include the requirement for
manual contouring and identification of landmarks in
the construction of the atlas. However, methods are be-
coming available for the fully automated determination
of LV contours and fiducial landmarks [33,34]. In the
near future it will be possible to generate large scale car-
diac atlases fully automatically. Another limitation is that
all CMR studies in the baseline MESA examination used
the fast gradient recalled echo protocol. The current
standard for cine CMR is steady state free precession
and this was used for the recent ten year follow-up
examination in MESA. It is well known that these proto-
cols give rise to different mass and volume measure-
ments, and also result in shape bias [35]. Methods to
remove such bias from models for the purposes of shape
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plied in future studies to examine the shape changes be-
tween baseline and follow-up MESA examinations. Future
work is also required to determine whether the strength of
the primary components is related to outcomes.
Due to the contouring and model fitting process, indi-
vidual variations of trabecular prominence and relatively
small features such as ‘crypts’ are not captured in the glo-
bal shape analysis. However, measures of trabeculation
(such as those described in [36]) can be correlated with
our dimensional shape measures, which could identify
possible relationships between shape and trabeculation.
Mitral annular dimensions are captured in the shape
model, since the model surfaces are defined up to the mi-
tral valve, which is considered as a simple plane. Mitral
valve plane variations were seen in the principal compo-
nents but have less power than size, sphericity and con-
centricity. However, partial voluming in the short axis
images near the mitral valve contributes to variability in
the measurement. More detailed modelling of the mitral
annulus shape would provide more insight into shape
changes [37].
Other shape features of clinical interest, such as LV
wall thickness and thickening, are also present in the
principal components. However they are not as powerful
as other components since the MESA participants were
asymptomatic and were not recruited for a particular
disease phenotype. If a PCA were constructed using a
significant number of HCM or DCM patients, we would
expect that the components would directly reflect wall
thickening or thinning in these patients. The use of
quasi-orthogonal components defined with a clinical ra-
tionale, such as hypertrophic or dilated cardiomyopa-
thies, is an interesting area of future research.
Conclusions
In conclusion, we have established the range of dimen-
sional shape variation in adult asymptomatic individuals.a b
Figure 4 Breath-hold correction. (a) original contours with a superimpos
breath-hold correction; (c) final fit with low stiffness and corrected contour
contours and surfaces are shown in red.Shape was dominated by components associated with
size, sphericity, and concentricity. These components
have been associated in the literature with adverse re-
modeling, and future work is needed to determine if
these components are also associated with adverse out-
comes in asymptomatic volunteers.
Appendix
The model comprised 16 bicubic finite elements defined
in a prolate spheroidal coordinate system. This enabled
an efficient representation of the shape of the left ven-
tricle as a radial function of two angular coordinates:
λ(μ,θ) (see [18,38] for details). Shape parameters of the
model were obtained from the epicardial and endocar-
dial surfaces. These parameters were evenly spaced
around the heart and intuitively control the position of
the model locally at each point. Figure 1c shows the
spatial distribution of the shape parameters.
The model was initialized by aligning and scaling the
generic model to the patient-specific coordinate system
and fiducial landmarks of each case. The model shape
parameters were then automatically fitted to the contour
points by linear least squares constrained optimization,
which minimized the surface error between the contour
points and the corresponding model points:
E λð Þ ¼ wS λð Þ þ
X
c
λ − λcð Þ2 ð1Þ
subject to the constraint that the epicardial surface had
to be placed outside the endocardial surface. Eqn. 1 was
minimized as a quadratic programming problem using
MATLAB’s Optimisation Toolbox (v. 6.0, The MathWorks
Inc., Natick, MA, USA). The influence of the smoothing
term S(λ) was controlled though the size of the weight w:
higher w gives less ripples in the surface (for details see
[39]). Controlling S(λ) is important since there is a trade-
off between smoothing and resolution, i.e. a highly smoothc
ed low- stiffness fit; (b) highly stiff model which serves as a guide for
s. Epicardial contours and surfaces are shown in blue; endocardial
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point of view, but might blur out smaller-scale anatomical
details.
Due to differences in breath-hold position between
slices, the model can exhibit artifactual ripples in the longi-
tudinal direction (Figure 4a). Although breath-hold mis-
registrations can result in 3D rotations and translations for
each slice, to a first order approximation these can be sub-
stantially removed by in-plane translations of the short axis
images [40]. To correct these mis-registrations, a three-
step process was employed. Firstly, Eqn. 1 was minimized
using high stiffness weights (w = 100) to fit the manual
uncorrected contours (Figure 4b). This provided a case-
specific smooth version of the model without longitudinal
ripples. Secondly, the intersection of the image plane with
the stiff model generated a new contour. An in-plane shift
vector was defined between the centroids of the manual
contour and the stiff model contour, and the manual con-
tour was shifted so that its centroid coincided with the
centroid of the stiff model contour. This ensured that the
shifts aligned the contours to a smooth version of the
anatomy. A final fit with low smoothing weight (w = 1)
was then performed to obtain the customized geometry
(Figure 4c).
In order to calculate statistical shape differences, the
endocardial and epicardial surfaces were sampled at high
density using a standardized sampling pattern (10 × 10
points per element) and the positions converted to rect-
angular Cartesian coordinates in mm. This led to a total
of 2738 points per model (duplicate points on element
boundaries were removed). This represented an over-
sampling of the model shape in order to ensure that all
shape characteristics were included to the extent of the
contour resolution.
Principal component analysis (PCA) was applied to
the sampled points from all models [11,14]. Briefly, the
sampled surfaces were aligned to remove variation due
to translation, rotation, and scale due to patient height.
The aligned point positions were assembled into a col-
umn vector for each case. The mean position of each
point was calculated by the arithmetic average across
cases and subtracted. Vectors from all cases were then
assembled into a shape matrix B. The covariance matrix
was calculated as
C ¼ N−1BBT ð2Þ
where N is the number of cases (N = 1,991).
In PCA, eigenvectors of the covariance matrix are com-
puted to give the principal components present in the
multi-variate point distributions, and their corresponding
eigenvalues give the variance for each component [21].
Typically, most of the variation can be explained by rela-
tively few components due to redundancy in the shapevectors. The first principal component shape is associated
with the largest eigenvalue and explains the greatest vari-
ance in the data. Each subsequent principal component
explains the maximum residual variation possible. The
strength of the principal component present in a particular
case can be found by projection of the shape vector onto
the direction defined by the corresponding eigenvector.
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